The FDA announced on 2022-10-12 that Boston Scientific Neuromodulation Corporation is voluntarily recalling Superion Indirect Decompression System devices due to potential weld breakage. The hazard may prevent proper device deployment during implantation.
How to tell if you have it
- Brand: Boston Scientific
- Product: Superion Indirect Decompression System (IDS)
- Model Numbers and Sizes: 101-9808 - 8mm, 01-9812 - 12mm, 101-9814 - 14mm
- UPN/GTIN Codes: 00884662000529, 00884662000543, 00884662000550
- Lot/Batch Numbers: 26176977, 26573432, 26375758, 26815560, 26807662, 26654632, 26928168, 26929605, 26489700, 26366842, 26848047, 26619510, 26323984, 26406210, 26799951
- Distribution: U.S. Nationwide including AL, AR, AZ, CA, CO, CT, FL, GA, HI, IL, IN, KS, LA, MI, MN, MS, NC, ND, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TX, UT, WI, WV, and WY
- Units Affected: 175 devices
The hazard
According to the FDA, the Superion Indirect Decompression System devices exhibit a potential for weld breakage at the spindle cap-to-main body interface. This separation may prevent proper deployment of the device during implantation.
Context
GovInfoNow's records show Boston Scientific Neuromodulation Corporation has had 12 other recalls on record since 2019-04-24. Recent recalls include the 2026-06-17 INFINION CX Lead Kits Recall for risk of lead fractures, the 2026-04-29 TCN Electrodes recall for not meeting performance levels, and the 2026-04-29 SC-4318 Clik X Anchor recall for lack of sterility assurance. Other recent recalls of similar products include the 2026-06-30 Rapid Refill System (risk of syringe disconnect), the 2026-07-09 ENROUTE Transcarotid Neuroprotection System (risk of arterial sheath tip separation), and the 2025-12-19 AXIOS Stent (deployment issues).